Respiratory Signs and Symptoms

Respiratory system manifestations of diseases of the respiratory tract or of other organs.

Also Known As:

Signs and Symptoms, Respiratory

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

1.	Chronic Obstructive Pulmonary Disease (COPD)
2.	Neutropenia
3.	Neoplasm Metastasis (Metastasis)
4.	Fever (Fevers)

1.	O'Brien, Christopher D: 2 articles (04/2012 - 04/2012)
2.	Soltaninia, Omid: 1 article (10/2015)
3.	Pourdanesh, Fereydoun: 1 article (10/2015)
4.	Moshref, Mohammad: 1 article (10/2015)
5.	Mohamadi, Mansoureh: 1 article (10/2015)
6.	Lee, Sang Kil: 1 article (02/2013)
7.	Park, Chan Hyuk: 1 article (02/2013)
8.	Lee, Yong Chan: 1 article (02/2013)
9.	Kang, Young Ae: 1 article (02/2013)
10.	Shin, Sung Kwan: 1 article (02/2013)

Drugs and Important Biological Agents (IBA) related to Respiratory Signs and Symptoms:

1.	Budesonide (Pulmicort)FDA LinkGeneric 04/01/2012 - "Three months' treatment with AZD9668 did not improve lung function, respiratory signs and symptoms or SGRQ-C score when added to budesonide/formoterol maintenance therapy in patients with COPD. "
2.	Biological Markers (Surrogate Marker)IBA 04/01/2012 - "AZD9668 showed no effect on lung function, respiratory signs and symptoms, QoL or biomarkers. "
3.	Carbon MonoxideIBA 01/01/2010 - "Characteristics evaluated included age, pregnancy status, sex, respiratory signs and symptoms, smoking and alcohol history, CURB-65 score, co-morbidities, disabling sequelae, length of stay and in-hospital mortality outcomes. "
4.	AsbestosIBA 05/01/1986 - "Exposed women presented certain respiratory signs and symptoms; they also had significantly lower forced vital capacities and maximal flow rates at higher (PEF), mid (MEF50%) and lower lung volumes (MEF25%) than women not exposed to asbestos. "
5.	Anti-Bacterial Agents (Antibiotics)IBA 02/01/2013 - "In patients with only lung consolidation (without respiratory signs and symptoms), the length of hospital stay and prognosis were not affected by antibiotics use. "
6.	formoterol (Oxis)FDA Link 04/01/2012 - "Three months' treatment with AZD9668 did not improve lung function, respiratory signs and symptoms or SGRQ-C score when added to budesonide/formoterol maintenance therapy in patients with COPD. "

1.	Transplantation (Transplant Recipients) 01/01/2012 - "However, the oral microbiome was affected in patients who developed respiratory signs and symptoms after transplantation. " 06/01/2010 - "The latter was more common in patients with leukaemia, cavitary lung lesions or consolidations, active underlying malignancy, neutropenia, respiratory signs and symptoms and/or fever, bone marrow transplant recipients, and in patients receiving chemotherapy. "
2.	Drug Therapy (Chemotherapy) 10/01/2015 - "Twenty months after final surgery and postoperative chemotherapy, lung metastases were diagnosed after she reported respiratory signs and symptoms. " 06/01/2010 - "The latter was more common in patients with leukaemia, cavitary lung lesions or consolidations, active underlying malignancy, neutropenia, respiratory signs and symptoms and/or fever, bone marrow transplant recipients, and in patients receiving chemotherapy. "
3.	Length of Stay 01/01/2010 - "Characteristics evaluated included age, pregnancy status, sex, respiratory signs and symptoms, smoking and alcohol history, CURB-65 score, co-morbidities, disabling sequelae, length of stay and in-hospital mortality outcomes. "